Drugs
-
Second Annual Meeting, Hepatotoxicity Steering Group Meeting, January 2003, Rockville, MD
- Mark Avigan, M.D., FDA
Issues Surrounding Identification of Drug-Induced Liver InjurY (PPT - 87KB) - Jose Serrano, M.D, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases
NIDDK Hepatotoxicity Network (PPT - 266KB) - Edwin J. Matthews, Ph.D., FDA
MCASE Prediction of Hepatotoxicity Using Post-Market Adverse Effects Data (PPT - 141KB) - Paul B. Watkins, University of North Carolina, Chapel Hill, N.C.
Identifying Susceptible Persons with Markers (PPT - 2MB)
-
-







